{"id":"W2597432644","doi":"10.1016/j.ejca.2017.01.024","title":"Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Prostate cancer; Abiraterone acetate; Internal medicine; Cancer; Cmax; Oncology; Pharmacology; Pharmacokinetics; Urology; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006459384,0.0002650382,0.0006511945,0.0002739178,0.000210274,0.0001271125,0.0003388724,0.00002518355,0.0001946013],"category_scores_gemma":[0.00006906309,0.0001553047,0.00007171476,0.0001897102,0.0001662821,0.0004983102,0.00007655814,0.000419922,0.000003535399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004411032,"about_ca_system_score_gemma":0.0008222811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005415476,"about_ca_topic_score_gemma":0.001537796,"domain_scores_codex":[0.9973958,0.000221004,0.0008173314,0.0002779285,0.0008789719,0.0004090144],"domain_scores_gemma":[0.9973883,0.00002960152,0.001159307,0.0004328754,0.0007372388,0.000252659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1081344,0.004655223,0.7777566,0.0003571488,0.001355677,0.00556025,0.01337654,0.00077967,0.007615567,0.000002228137,0.0007218075,0.07968488],"study_design_scores_gemma":[0.09114663,0.01187283,0.8907031,0.001406884,0.0002989536,0.00001337206,0.0009783518,0.00002810169,0.002509415,0.0000014349,0.0008376614,0.0002032668],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964504,0.001014212,0.000003583196,0.0004652621,0.0002980925,0.001039353,0.00007674933,0.000007523608,0.0006448362],"genre_scores_gemma":[0.9973897,0.0005969671,0.00007039572,0.00003032488,0.0002236739,0.00002166914,0.000007425252,0.00006321484,0.001596637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1129465,"threshold_uncertainty_score":0.6333141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07111369384903171,"score_gpt":0.3939819211044353,"score_spread":0.3228682272554036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}